Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00698789

Public ClinicalTrials.gov record NCT00698789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Determine the effect of treatment with INCB019602 administered as an add-on to stable dose metformin therapy in type 2 diabetic subjects on safety and glycemic control.

Study identification

NCT ID: NCT00698789
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: Incyte Corporation; Industry
Enrollment: 48 participants

Conditions and interventions

Conditions

Type 2 Diabetes

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 2008 (Type not available)
Primary completion: Feb 2009 (Actual)
Completion: Jun 2009 (Actual)
Last update posted: Oct 30, 2012

2008 – 2009

United States locations

U.S. sites: 22
U.S. states: 14
U.S. cities: 22

Facility	City	State	ZIP	Site status
Not listed	Phoenix	Arizona	85029	—
Not listed	Tucson	Arizona	85705	—
Not listed	Chula Vista	California	91911	—
Not listed	Los Angeles	California	—	—
Not listed	Mission Viejo	California	92691	—
Not listed	Orange	California	92869	—
Not listed	Paramount	California	90723	—
Not listed	San Diego	California	92117	—
Not listed	Santa Ana	California	92701	—
Not listed	Tustin	California	92780	—
Not listed	Colorado Springs	Colorado	80909	—
Not listed	St. Petersburg	Florida	33709	—
Not listed	Shawnee Mission	Kansas	66216	—
Not listed	Shreveport	Louisiana	71101	—
Not listed	Dearborn	Michigan	48126	—
Not listed	St Louis	Missouri	63110	—
Not listed	Omaha	Nebraska	68154	—
Not listed	Elizabeth	New Jersey	07202	—
Not listed	Charlotte	North Carolina	28211	—
Not listed	Oklahoma City	Oklahoma	73103	—
Not listed	East Providence	Rhode Island	02914	—
Not listed	San Antonio	Texas	78229	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00698789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 30, 2012 · Synced Oct 17, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00698789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →